Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, News, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-Jun-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 12)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
19-Jun-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
17-Jun-13 Alpha Street Research Hunter Orr GILD - Gilead Sciences Inc - Upgraded to a Buy - Company Analysis and ASR Ranking Report 9 $24 View Abstract
17-Jun-13 Pechala's Reports Lubomir Pechala GILEAD SCIENCES INC (GILD) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
15-Jun-13 S&P Capital IQ – STARS Reports N/A Gilead Sciences 10 $115 View Abstract
15-Jun-13 Pechala's Reports Frantisek Pechala GILEAD SCIENCES INC (GILD) 12-months forecast 1 $15 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) 105 $1207.50 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) 78 $897 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) 77 $885.50 View Abstract
14-Jun-13 Ford Investor Services, Inc. N/A Industry Value Graph: ALXN , AMGN , BIIB , GILD -- DRUGS 3 $34.50 View Abstract
14-Jun-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of GILEAD SCIENCES INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
Next 2

Independent Reports (Showing 1 to 10 of 12)

Release
Date Contributor Author Title Pages Price More Info
19-Jun-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
17-Jun-13 Alpha Street Research Hunter Orr GILD - Gilead Sciences Inc - Upgraded to a Buy - Company Analysis and ASR Ranking Report 9 $24 View Abstract
17-Jun-13 Pechala's Reports Lubomir Pechala GILEAD SCIENCES INC (GILD) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
15-Jun-13 S&P Capital IQ – STARS Reports N/A Gilead Sciences 10 $115 View Abstract
15-Jun-13 Pechala's Reports Frantisek Pechala GILEAD SCIENCES INC (GILD) 12-months forecast 1 $15 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) 105 $1207.50 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) 78 $897 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) 77 $885.50 View Abstract
14-Jun-13 Ford Investor Services, Inc. N/A Industry Value Graph: ALXN , AMGN , BIIB , GILD -- DRUGS 3 $34.50 View Abstract
14-Jun-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of GILEAD SCIENCES INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
Next 2

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.